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Abstract 
Many diseases are associated with the mutation of wild-type proteins. Usually, a point mutation can lead to severe clinical 
outcomes. Few techniques have the ability to detect the minute differences between the wild-type and mutant proteins in solution
under near physiological conditions. Circular dichroism (CD) is an established and valuable technique for examining protein 
structure. Because of its ability to sensitively detect conformational changes, it has important potential for identification of
mutant protein. Synchrotron radiation CD (SRCD) offers significant enhancements with respect to conventional CD spectroscopy, 
which will enable its usage for high-resolution conformation detection and as a tool in the point-mutation protein identification. 
In this report, SRCD was used, as an example, to identify the point-mutations of human phosphoribosyl pyrophosphate 
synthetase 1 which were associated with an X chromosome-linked disease. 
© 2010 Published by Elsevier Ltd. 
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1. Introduction 
Synchrotron radiation circular dichroism (SRCD) spectroscopy is an emerging technique which offers significant 
improvements to the well-established method of conventional circular dichroism (cCD) spectroscopy. It takes 
advantage of the higher light flux available from synchrotron sources, which results in lower wavelength data, 
higher information content and improved signal-to-noise ratios [1]. It is noteworthy that SRCD has enabled us to 
measure a functionally-significant difference between the wild-type and disease-associated mutant protein in 
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solution that was not feasible using either cCD or X-ray crystallography. The latter is also because that no crystals 
have yet been obtained for the mutant although a crystal structure has been obtained for the native protein [2].  
Human phosphoribosylpyrophosphate synthetase 1 (hPRS1), catalyzing the reaction of ribose-5-phosphate with 
ATP to yield 5-phosphoribosyl-a-1-pyrophosphate and AMP. Superactivity of mutant hPRS1 is an X-linked disorder 
of purine metabolism characterized by gout with uric acid overproduction [3] and neurodevelopmental impairment 
in some affected families [4]. Compared to wild-type hPRS1, a residue is replaced in the amino acid sequence of 
hPRS1 of the patients. Six point-mutants of hPRS1 have been found [5]. Point mutations provide the genetic basis 
for regulatory defects, indicating the functional significance of these amino-acid residues in hPRS1. Li et al. have 
reported the structure of hPRS1 [6]. To date, however, more details about how point mutations affect the regulatory 
mechanism of hPRS1 are not available. This situation is partly due to the difficulty in point-mutation protein 
crystallization. In this report, we have used SRCD spectroscopy to study the secondary structures of wild-type 
hPRS1 and its two point-mutants: D52H and N114S in solution. We have detected slightly but significantly 
alterations in secondary structures associated with single point mutations. Two patterns were suggested about how 
the point mutation affects the allosteric regulatory mechanism. 
2. Materials and Methods 
2.1 Sample preparation 
Three proteins: wild-type hPRS1, D52H, and N114S were obtained. The protein expression and purification were 
as described in [7]. The accurate determination of protein concentration was to measure the absorbance of the 
protein at 280 nm when it was denatured in 6 M guanidinium hydrochloride. For native and mutant hPRS1, the same 
calculated extinction coefficients of 0.530 were obtained [8]. 12% cross-linked polyacrylamide gels were prepared 
according to the method of Davis. SDS-PAGE gels were analyzed by staining with 0.1% Coomassiebrilliant blue. 
All proteins after purification were dialyzed against the buffer system with 20 mM sodium phosphate and 100 
mM sodium sulphate (pH 8.0) to remove the strongly absorption of chlorine anions in the lower wavelength region 
and to provide sufficient ionic strength to keep the proteins stable. After dialysis, samples were centrifuged at 
14,000 rpm for 10 min at 4ć. The protein was omitted from the solution in the control samples. All the prepared 
samples were degassed under vacuum condition before measurements to avoid optical artifacts such as differential 
light scattering and absorption flattening [9,10]. 
2.2 SRCD experiments 
SRCD spectra were recorded on Beamline 4B8 at the BSRF (Beijing, China), and at Beamline U25 at NSRL 
(Hefei, China) respectively, using a scan speed of 120 nm/min, a time constant of 2 s and a bandwidth of 1 nm. 
Spectra were collected at a protein concentration of 0.7 mg/ml, at a temperature of 25°C controlled by a BTEC-77b 
temperature controller. Three scans of each spectrum over a wavelength range from 175 nm to 270 nm were 
averaged, smoothed, and baselines subtracted. In all measurements, the same sample cuvette with pathlengths of 
0.01 cm (Hellma Ltd) was used. SRCD instrument was calibrated using camphor sulphonic acid. All spectra were 
only recorded down to wavelengths where the instrument dynode voltage indicated that the detection was still within 
the linear range. Spectra were converted to delta epsilon units using a mean residue weight value of 109.6. Data 
processing was performed using the CDTool software suite. [11] 
2.3 Secondary structure analyses 
The secondary structure analyses of SRCD spectra were performed on the DICHROWEB [12], using the self-
consistent method CONTINLL and the SELCON3 method based on the 29 reference proteins dataset from Johnson 
et al.[13] The SRCD performance, į, was characterized by the root mean square deviations (RMSD) between the 
DSSP assignment and the SRCD estimate. The quality of the fit of the calculated data to the experimental data was 
characterized by the normalized RMSD, whose values of ˘0.1 mean that they are in close agreement. [14] 
3. Results and Discussion 
The purified proteins showed a major band of 35 kDa on SDS–PAGE, which were in good agreement with the 
calculated value of 34.8 kDa (Fig. 1a). The SRCD spectrum of three proteins produced by two beamlines are same. 
As showed in Fig. 1b, the wild-type hPRS1 gives rise to a spectrum that is characteristic of a protein with Į/ȕ
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tertiary structure [15], having peaks at ~222, 208, and 192 nm and a cross-over from positive to negative near 
177nm. And the 222 nm band is of lager magnitude and more prominent than the 208 nm band. Compared to wild-
type hPRS1, D52H has a significant increase in magnitude of the 208 nm peak and there is a significant increase of 
the ȕ-strand and turn structures as showed in Table 2. N114S has an increase in magnitudes of the peaks 222, 192nm, 
and its peak of 208nm has the same magnitude with that of wild-type hPRS1. The calculated results show the 
slightly increase of Į-helix content. 
Fig. 1. (a) SDS–PAGE of hPRS1. Lane M, molecular-weight markers (kDa); Lane 1 to 2, purified fraction from Gel filtration 
(more than 95% purity) of wild-type hPRS1, N114S and D52H, respectively. (b) SRCD spectra of purified wild-type hPRS1, 
D52H, and N114S mutation. The error bars represent one standard deviation in the repeated measurements from three sequential 
scans of both spectra and baselines. (c) Crystal structure of wild-type hPRS1 two subunits highlighted in green and cyan, 
respectively. The D52 and N114 residues are in red and orange, respectively.  
As showed in Table 1, the secondary structures generated from SRCD spectra using the CONTINLL analyses 
method are accordant with the secondary structures in crystal assigned by DSSP program. This increases our 
confidence level in the accuracy of SRCD technique. The data of CONTINLL analyse, which are similar with the 
SELCON3 analyse (data not shown), show that both the į and NRMSD factors are small. As showed in Table 2, the 
point mutation causes slightly but significantly alterations in secondary structures. These alterations should be the 
structural basis of the regulatory defects of hPRS1 activity. It is possible to influence the activity of the enzyme from 
a mutational site distinct from where the reaction takes place on the enzyme. Therefore, the severe clinical diseases 
appear. 
Table 1. Secondary-structure contents of wild-type hPRS1 determined by DSSP assignment and SRCD analysis. 
Protein ĮR ĮD ȕR ȕD Turn Unordered Total NRMSD a įb
Wild-type 
DSSP 20.7 16.2 15.5 8.5 13.7 25.4 100 — — 
SRCD 18.1 13.9 8.9 7.3 22.1 29.7 100.0 0.020 0.049 
Table 2. Secondary-structure contents of wild-type hPRS1, D52H and N114S mutations determined by SRCD spectra in the 
wavelength region from 260nm to 175nm. The number of helix and strand segments is given per protein molecule corresponding 
to one subunit in the asymmetric unit of the X-ray structure.
Protein Secondary Structure (%) Number of helix and strand segments NRMSDĮ-Helix ȕ-Strand Turn Unordered Į-Helix ȕ-Strand
Wild-type 32.0 16.2 22.1 29.7 11 12 0.020 
D52H 32.2 19.5 23.4 24.9 11 13 0.024 
N114S 32.9 16.0 21.1 30.0 11 11 0.029 
The X-Ray results show that D52 residue is located at the interface between three subunits of the hexamer where 
the ADP allosteric site is. D52H mutation might cause alteration of the space structure of the ADP binding site, by 
what the regulatory defect is caused. The N114S mutation induces the increase of the length of some helix. This 
residue is located at the Į3 helix that is next to the flexible loop. If we considered that the length of Į3 helix 
increased, the conformation of the flexible loop should be certainly changed. These results also agree well with the 
point that the allosteric regulation mainly occurs at the interfaces between subunits of the hexamer [6,16]. 
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In conclusion, we have observed slightly but significantly conformational alterations in secondary structure of 
hPRS1 caused by D52H and N114S point-mutations. The SRCD spectra show enough accuracy to distinguish the 
point-mutation-induced alteration of the protein conformation. SRCD offers significant enhancements with respect 
to cCD spectroscopy, which will enable its usage for high-resolution conformation detect and as a tool in the point-
mutation protein identification. 
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